ESR1 and breast cancer: Furthermore, we have observed that similar to PI treatment, knockdown of FOXM1 in MCF7 cells caused down-regulation of numerous genes whose expression correlates with resistance to endocrine therapy, decreased sensitivity to chemotherapy, poor prognosis and decreased metastasis-free survival in ERα+ breast cancer patients [34].